PLASMA APOC-III LEVELS, TRIGLYCERIDES, AND CORONARY ARTERY CALCIFICATION IN TYPE 2 DIABETICS

被引：0
|
作者：
Qamar, Arman [1 ]
Khetarpal, Sumeet [1 ]
Khera, Amit [1 ]
Qasim, Atif [1 ]
Reilly, Muredach [1 ]
Rader, Daniel [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)61373-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1107-108
引用
收藏
页码：A1373 / A1373
页数：1
相关论文
共 50 条
  • [1] Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics
    Qamar, Arman
    Khetarpal, Sumeet A.
    Khera, Amit V.
    Qasim, Atif
    Rader, Daniel J.
    Reilly, Muredach P.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (08) : 1880 - 1888
  • [2] Targeting apoc-III to lower triglycerides
    Karina Huynh
    Nature Reviews Cardiology, 2015, 12 (2) : 64 - 64
  • [3] ApoC-III gene polymorphisms and risk of coronary artery disease
    Olivieri, O
    Stranieri, C
    Bassi, A
    Zaia, B
    Girelli, D
    Pizzolo, F
    Trabetti, E
    Cheng, S
    Grow, MA
    Pignatti, PF
    Corrocher, R
    JOURNAL OF LIPID RESEARCH, 2002, 43 (09) : 1450 - 1457
  • [4] ApoC-III is a novel inducer of calcification in human aortic valves
    Schlotter, Florian
    Freitas, Renata C. C. de
    Rogers, Maximillian A.
    Blaser, Mark C.
    Wu, Pin-Jou
    Higashi, Hideyuki
    Halu, Arda
    Iqbal, Farwah
    Andraski, Allison B.
    Rodia, Cayla N.
    Kuraoka, Shiori
    Wen, Jennifer R.
    Creager, Michael
    Tan Pham
    Hutcheson, Joshua D.
    Body, Simon C.
    Kohan, Alison B.
    Sacks, Frank M.
    Aikawa, Masanori
    Singh, Sasha A.
    Aikawa, Elena
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [5] Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma
    Nguyen, Minh N.
    Chan, Dick C.
    Dwyer, Kevin P.
    Bolitho, Paul
    Watts, Gerald F.
    Barrett, P. Hugh R.
    JOURNAL OF LIPID RESEARCH, 2006, 47 (06) : 1274 - 1280
  • [6] ApoC-III is a novel inducer of calcification in human aortic valves
    Schlotter F.
    De Freitas R.C.C.
    Rogers M.A.
    Blaser M.C.
    Wu P.-J.
    Higashi H.
    Halu A.
    Iqbal F.
    Andraski A.B.
    Rodia C.N.
    Kuraoka S.
    Wen J.R.
    Creager M.
    Pham T.
    Hutcheson J.D.
    Body S.C.
    Kohan A.B.
    Sacks F.M.
    Aikawa M.
    Singh S.A.
    Aikawa E.
    Journal of Biological Chemistry, 2021, 296
  • [7] Targeting ApoC-III to Reduce Coronary Disease Risk
    Sumeet A. Khetarpal
    Arman Qamar
    John S. Millar
    Daniel J. Rader
    Current Atherosclerosis Reports, 2016, 18
  • [8] CORONARY ARTERY DISEASE-PROTECTIVE A43T VARIANT IN APOC3 ALTERS CIRCULATING APOC-III LEVELS IN VIVO
    Khetarpal, S.
    Varshini, A.
    Larach, D.
    Tabita-Martinez, J.
    McParland, J.
    McCoy, M.
    Rodrigues, A.
    Kiss, D.
    Zanoni, P.
    Mucksavage, M.
    Millar, J.
    Cuchel, M.
    Lund-Katz, S.
    Phillips, M.
    Kathiresan, S.
    Rader, D.
    ATHEROSCLEROSIS, 2015, 241 (01) : E37 - E37
  • [9] Targeting ApoC-III to Reduce Coronary Disease Risk
    Khetarpal, Sumeet A.
    Qamar, Arman
    Millar, John S.
    Rader, Daniel J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (09)
  • [10] Abnormal apoC-III distribution and reduced cholesterol efflux capacity of plasma in normolipidemic subjects with premature coronary artery disease
    Delplanque, B
    Le Roy, B
    Senault, C
    Peterson, G
    Thaminy-Dekar, A
    Tavella, M
    Alaupovic, P
    Mendy, F
    OCL-OLEAGINEUX CORPS GRAS LIPIDES, 2002, 9 (04): : 227 - 231
12345